Endocrinology
FDA Approves Cymbalta for Diabetic Peripheral Neuropathic Pain
The U.S. Food and Drug Administration (FDA) has given its approval to Cymbalta (duloxetine HCl), a groundbreaking antidepressant that can effectively manage diabetic peripheral neuropathic pain, a symptom of nerve damage that affects up to 5 million Americans. Cymbalta, a serotonin and norepinephrine reuptake inhibitor, is the first and